Literature DB >> 18417501

Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.

Tomo Osako1, Masahiko Oguchi, Madoka Kumada, Keiko Nemoto, Takuji Iwase, Takashi Yamashita.   

Abstract

OBJECTIVE: To evaluate acute morbidity, radiation dermatitis and pneumonitis, of Japanese patients treated with whole breast hypofractionated radiotherapy (RT) after breast-conserving surgery (BCS), compared to conventional RT.
METHODS: Japanese patients who received whole breast RT after BCS between October 2003 and September 2006 were retrospectively reviewed. Patients who had selected the conventional or hypofractionated schedule received whole breast irradiation of 50 Gy in 25 fractions plus boost or 40 Gy in 16 fractions plus boost. Radiation dermatitis and symptomatic pneumonitis were graded according to the Common Terminology Criteria for Adverse Events version 3.0.
RESULTS: Of 443 consecutive patients, 377 (85%) received the conventional schedule and 66 (15%) received the hypofractionated schedule. Of patients treated with the conventional schedule, Grade 0, 1, 2 and 3 radiation dermatitis were observed in 16 (4%), 278 (74%), 77 (20%) and 6 (2%), respectively. Of patients treated with the hypofractionated schedule, Grade 0, 1, 2 and 3 dermatitis were observed in 11 (17%), 49 (74%), 5 (8%) and 1 (1%), respectively. Grade 2-3 dermatitis by the hypofractionated schedule (9%) was observed less frequently than that by the conventional schedule (22%) (chi-square test; P = 0.016). Moreover, of patients treated with the conventional schedule, 4 (1%) had Grade 2 radiation pneumonitis. No patient treated with the hypofractionated schedule had symptomatic pneumonitis.
CONCLUSIONS: Radiation dermatitis and pneumonitis in Japanese patients treated with the hypofractionated schedule is acceptable. Especially, radiation dermatitis by the hypofractionated schedule is milder than that by the conventional schedule.

Entities:  

Mesh:

Year:  2008        PMID: 18417501     DOI: 10.1093/jjco/hyn030

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.

Authors:  Jens-Michael Jensen; Tanja Gau; Jürgen Schultze; Gunter Lemmnitz; Regina Fölster-Holst; Theodor May; Christoph Abels; Ehrhardt Proksch
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

2.  Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity.

Authors:  Letizia Deantonio; Giuseppina Gambaro; Debora Beldì; Laura Masini; Sara Tunesi; Corrado Magnani; Marco Krengli
Journal:  Radiat Oncol       Date:  2010-11-23       Impact factor: 3.481

3.  Intensity-modulated radiotherapy using two static ports of tomotherapy for breast cancer after conservative surgery: dosimetric comparison with other treatment methods and 3-year clinical results.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koji Inoda; Yuzo Kikuchi
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

4.  Impact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer.

Authors:  Milena Mako Suesada; Heloisa de Andrade Carvalho; André Luis Pereira de Albuquerque; João Marcos Salge; Silvia Radwanski Stuart; Teresa Yae Takagaki
Journal:  J Bras Pneumol       Date:  2018 Nov-Dec       Impact factor: 2.624

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.